Analyse
Analysis, methods and insights to drive your digital transformation and master AI.
The Real Cost of Software Subscriptions for a Swiss SME
The subscription bill is only the visible part of an SME's software cost. Four items appear nowhere: teams adapting to the tools' limitations, price hikes absorbed without question, captive data, and exit costs never budgeted for. A one-hour inventory method, and what to do with the total.
8 min
The cost of custom software in the age of AI-augmented development
Pre-2023 cost benchmarks no longer hold, but not everything has gotten cheaper. Three tiers for reasoning without a made-up number, and what remains expensive despite code assistants: integration, migration, quality, maintenance.
8 min
What Skills Can't AI Replace? Six Answers
AI removes tasks, not jobs — and that distinction changes everything for employment and training. Six skills structurally resist this wave. An analysis from Valais, where the vineyard already illustrates the mechanics.
9 min
Perplexity or Google: where your customers search in 2026
Your customers haven't left Google for Perplexity: they alternate between several search regimes depending on their need. What each environment reveals about your business, and how to measure without picking the wrong terrain.
8 min
AI and developers: who is still building, if AI writes the code?
Generative AI writes functional code, fast. It doesn't design the architecture, doesn't check its own output, and carries no responsibility. The developer's value is shifting — and so is the brief a Swiss SME needs to write.
8 min
E-commerce and AI: Are your products being cited?
Product search is partly shifting to ChatGPT, Perplexity, and Google's AI Mode. What these environments read on a product page, the Swiss guardrails to respect, and the three trade-offs facing merchants in 2026.
8 min
AI in Swiss healthcare: what a regulated sector allows
Healthcare is Switzerland's most regulated sector, yet AI is already running there in routine use: imaging, administration, clinical research. What this terrain demonstrates holds for any executive operating under regulatory constraint — the rule selects serious projects, it does not block them.
9 min